Yunnan Baiyao Group Co.,Ltd (SHE: 000538)

Market Cap	102.70B
Revenue (ttm)	39.34B
Net Income (ttm)	4.30B
Shares Out	1.78B
EPS (ttm)	2.40
PE Ratio	23.98
Forward PE	19.28
Dividend	2.08 (3.62%)
Ex-Dividend Date	Nov 25, 2024

Volume	6,274,237
Average Volume	6,093,820
Open	56.93
Previous Close	57.35
Day's Range	56.93 - 58.33
52-Week Range	45.04 - 67.10
Beta	0.42
RSI	47.32
Earnings Date	Apr 1, 2025

About SHE:000538

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally. It provides health products; drugs; medical devices; traditional Chinese medicine resources; and tea products. The company also supplies and distributes medicines. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1902
• Employees: 8,834
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000538

Financial Performance

In 2023, SHE:000538's revenue was 39.11 billion, an increase of 7.19% compared to the previous year's 36.49 billion. Earnings were 4.09 billion, an increase of 36.41%.